InvestorsHub Logo
Followers 12
Posts 644
Boards Moderated 0
Alias Born 06/12/2013

Re: postes post# 283125

Saturday, 06/27/2020 2:37:47 AM

Saturday, June 27, 2020 2:37:47 AM

Post# of 429031
Oh really?

Likewise, Dr.
Budoff “treated patients with Vascepa for less than 12 weeks about 5% of the time, which is consistent with [the] labelling.” (yes the defendants directly cited and managed to misspell labeling)


So as I pointed out months ago on this board, if the label is only promoting 5% usage and there is no evidence that Hikma plans to infringe then why are they advertising Vascepa's entire sales volume to investors in press releases?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News